- Home
- AXGN vs RLAY Comparison
AXGN vs RLAY Comparison
Compare AXGN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- RLAY
- Stock Information
- Founded
- AXGN N/A
- RLAY 2015
- Country
- AXGN United States
- RLAY United States
- Employees
- AXGN N/A
- RLAY N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXGN Health Care
- RLAY Health Care
- Exchange
- AXGN Nasdaq
- RLAY Nasdaq
- Market Cap
- AXGN 538.3M
- RLAY 490.3M
- IPO Year
- AXGN N/A
- RLAY 2020
- Fundamental
- Price
- AXGN $10.41
- RLAY $3.36
- Analyst Decision
- AXGN Strong Buy
- RLAY Strong Buy
- Analyst Count
- AXGN 6
- RLAY 11
- Target Price
- AXGN $23.83
- RLAY $18.40
- AVG Volume (30 Days)
- AXGN 587.0K
- RLAY 1.4M
- Earning Date
- AXGN 05-08-2025
- RLAY 05-05-2025
- Dividend Yield
- AXGN N/A
- RLAY N/A
- EPS Growth
- AXGN N/A
- RLAY N/A
- EPS
- AXGN N/A
- RLAY N/A
- Revenue
- AXGN $194,520,000.00
- RLAY $7,679,000.00
- Revenue This Year
- AXGN $18.08
- RLAY $14.58
- Revenue Next Year
- AXGN $16.15
- RLAY N/A
- P/E Ratio
- AXGN N/A
- RLAY N/A
- Revenue Growth
- AXGN 18.81
- RLAY N/A
- 52 Week Low
- AXGN $6.59
- RLAY $1.78
- 52 Week High
- AXGN $21.00
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- AXGN 29.55
- RLAY 62.06
- Support Level
- AXGN $10.65
- RLAY $3.16
- Resistance Level
- AXGN $11.24
- RLAY $3.39
- Average True Range (ATR)
- AXGN 0.49
- RLAY 0.21
- MACD
- AXGN 0.12
- RLAY 0.04
- Stochastic Oscillator
- AXGN 7.24
- RLAY 85.92
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).